Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | 0.00% |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
03-05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
0.00% | 21.12M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production